Demet Timur

Dr. Demet Timur


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
EYEdanur Yesil
Edanur Yesil
SÇSolmaz Çelebi
Solmaz Çelebi
MEMelike Sezgin Evim
Melike Sezgin Evim
AÖArife Özer
Arife Özer
CTCansu Turan
Cansu Turan
MHMustafa Kemal KEMAL Hacımustafaoğlu
Mustafa Kemal KEMAL Hacımustafaoğlu

1 August 2026 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
EGEmel Gürcüoğlu
Emel Gürcüoğlu
GÇGülbahar Çalışkan
Gülbahar Çalışkan
MBMÜZEYYEN tuğçe BENLİ
MÜZEYYEN tuğçe BENLİ
DTDemet Timur
Demet Timur
Background: In catheter-related candidemia, a true catheter-source infection is often difficult to distinguish from a catheter that merely marks critical illness. Our primary aim was to identify predictors of 30-day mortality; secondary aims were to characterize species-specific patterns of persistent candidemia, its prognostic meaning within the host immune–inflammatory context, and the relationship between echinocandin therapy and secondary bacterial bloodstream infection (BSI). Methods: We retrospectively reviewed 89 consecutive episodes of catheter-related candidemia at Bursa City Hospital (2021–2025). Catheter association required Candida spp. growth in concurrent catheter and peripheral blood cultures. The primary endpoint was 30-day mortality; persistent candidemia (≥72 h) and secondary bacterial BSI on days 3–30 were evaluated as exploratory endpoints. Raw MIC values were retrospectively reinterpreted according to EUCAST v12.1 breakpoints (effective 10 April 2026). Results: Thirty-day mortality was 53.9% (48/89). The multivariable model was significant (LR χ2 = 12.12, df = 4, p = 0.017; Nagelkerke R2 = 0.170); NLR was not significantly associated with mortality (OR = 1.061, 95% CI 1.00–1.13, p = 0.064). Catheter removal, initial echinocandin therapy, and persistent candidemia were not independent predictors, though catheter retention was associated with higher mortality on univariable analysis (83.3%; p = 0.033). Persistent candidemia occurred in 51.7% of episodes, most notably with C. parapsilosis and C. auris. The NLR-persistence interaction was not formally significant, but mortality was higher when both co-occurred (66.7% vs. 36.4%; OR = 3.50, p = 0.075). Secondary BSI occurred in 28.4% of episodes and was more frequent in the echinocandin group (39% vs. 20%; p = 0.062); sensitivity analyses did not change the main findings. Conclusions: Mortality could not be explained by antifungal choice alone; these findings are exploratory. Host response, source control, species distribution, survival time, and device exposure are possible contributing factors warranting evaluation in prospective studies.

31 March 2023 in Medical Research Reports
Verified
Journal Article
Open access
PDF file
DTDemet Timur
Demet Timur
ÖPÖmür Mustafa Parkan
Ömür Mustafa Parkan
HKHüseyin Kiliç
Hüseyin Kiliç
MAMustafa Altay Atalay
Mustafa Altay Atalay
FTFatma Filiz Teki̇nŞen
Fatma Filiz Teki̇nŞen
AKAyşe Nedret KOÇ
Ayşe Nedret KOÇ
Amaç: Mycobacterium tuberculosis tanısında Ehrlich-Ziehl Neelsen (EZN) gibi aside dirençli boyama yöntemleri hızlı ve uygulaması kolay yöntemler olmasına rağmen kesin sonuç vermemektedir. Kültür yöntemleri altın standart olarak kabul edilmesine rağmen zaman alıcı yöntemlerdir. Nükleik asit amplifikasyon testleri ise sonuç verme süreleri kısa olduğu için tüberkülozun hızlı tanısında çok sık olarak kullanılmaktadır. Bu çalışmada, tüberküloz şüpheli klinik örneklerde GeneXpert MTB/RIF yöntemi ve artus® MTB-PCR yönteminin değerlendirilmesi amaçlanmıştır. Yöntem: Erciyes Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı Mikobakteriyoloji Laboratuvarına Ocak-Aralık 2013 tarihleri arasında gönderilen 432 klinik örnek EZN yöntemiyle boyanmıştır. Örnekler homojenize ve dekontamine edildikten sonra, BACTEC MGIT 960 kültür şişeleri ile eş zamanlı olarak Löwenstein-Jensen besiyerlerine ekim yapılmıştır. Nükleik asit amplifikasyon testi olarak örneklerin 196’sında GeneXpert MTB/RIF yöntemi, 236’sında da artus® MTB-PCR yöntemi kullanılmıştır. Bulgular: Toplam 432 klinik örneğin 8’i (%1.9) EZN yöntemi ile, 20’si (%4.6) kültür yöntemleri ile pozitif olarak bulunmuştur. Kültür yönteminin altın standart kabul edildiği bu çalışmada, EZN boyama, artus® MTB-PCR ve GeneXpert MTB/RIF yöntemlerinin duyarlılığı sırasıyla %35, %42.9 ve %83.3; özgüllüğü sırasıyla %99.7 %99.1 ve %97.9 olarak saptanmıştır. Sonuç: Bu çalışmada GeneXpert MTB/RIF ile artus® MTB-PCR yöntemleri tüberküloz tanısında benzer özgüllüğe sahiptir. Fakat GeneXpert MTB/RIF yönteminin yüksek duyarlılığı ve hızlı sonuç vermesi dikkat çekmektedir. Bu iki yöntemin eş zamanlı olarak karşılaştırılmasının, herhangi bir analitik tutarsızlığı kontrol etmeyi mümkün kılacağını değerlendirmekteyiz.

9 June 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
DTDemet Timur
Demet Timur
CDCanan Demir
Canan Demir
Candida auris (Candidozyma auris) differs from other yeast species by its ability to persist for prolonged periods on environmental surfaces and human skin. This feature facilitates person-to-person transmission and contributes to healthcare-associated infections and outbreaks. In this study, both invasive C. auris infections and colonization were evaluated together. We aimed to compare clinical characteristics and healthcare-associated exposures between invasive and colonized cases and to assess antifungal susceptibility patterns in invasive infections. A total of 79 patients with C. auris isolation between December 2022 and April 2025 were retrospectively analyzed. Species identification was confirmed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Patients with C. auris isolated from invasive specimens, such as blood or tissue, were classified as having invasive infection, whereas those with isolation from non-invasive specimens such as axilla/groin swabs, nasal swabs, urine, catheters, and sputum, without concurrent invasive positivity, were classified as colonized. Patients with both screening and invasive positivity were included in the invasive infection group for comparative analyses. Antifungal susceptibility to amphotericin B, fluconazole, micafungin, and anidulafungin was determined on invasive isolates using the Sensititre YeastOne colorimetric microdilution method. Interpretation of results was based on the tentative breakpoints defined by the United States Centers for Disease Control and Prevention and the epidemiological cutoff values established by the European Committee on Antimicrobial Susceptibility Testing. Demographic characteristics, clinical variables, and healthcare-associated exposures were compared between the invasive infection and colonization groups. A total of 91 C. auris isolates from 79 patients were evaluated. Invasive infection was detected in 41 patients (52%) and colonization in 38 patients (48%). Most cases were observed in intensive care and palliative care units. Among screening sites, axilla/groin swabs showed the highest positivity rate. Central venous catheter use, intubation, surgical history, and decubitus ulcer were numerically more frequent among invasive cases; however, none of these differences reached statistical significance. Echinocandin resistance developed in two patients during follow-up. The median age was significantly higher in the invasive group than in the colonized group (74 vs. 64.5 years; p = 0.002). Accurate identification of C. auris and continuous antifungal susceptibility surveillance are essential for infection control. Older age was the only variable significantly associated with invasive infection, while other clinical and healthcare-associated exposures were common in both groups but did not differ significantly. All isolates were resistant to fluconazole, and echinocandin resistance emerged in two isolates. Amphotericin B susceptibility findings should be interpreted cautiously, as the use of Sensititre YeastOne without confirmatory reference testing may have overestimated resistance. Larger multicenter studies are needed to better define factors independently associated with invasive infection.

19 May 2022 in medRxiv
Verified
Preprint
Open access
PDF file
DTDemet Timur
Demet Timur
UDUğur Demirpek
Uğur Demirpek
EEEngin Ertek
Engin Ertek
ÖAÖzlem Çetinkaya Aydın
Özlem Çetinkaya Aydın
TKTalha Karabıyık
Talha Karabıyık
HKHüseyin Kayadibi
Hüseyin Kayadibi
Since December 2019, after the declaration of new cases regarding novel coronavirus disease, many variants have emerged as a consequence of the viral evolution. Though the SARS-CoV-2 variants have been studied for molecular basis, the clinical and pathologic disparities of them have been understood inadequately. The aim of this research was to figure out the differences between the SARS-CoV-2 Alpha (B1.1.7) variant and the classical Wuhan groups on the clinical basis and laboratory results of the COVID-19 patients who had positive PCR test.The study was done retrospectively inclusive of epidemiological, laboratory data and clinical symptoms of patients who were admitted to the emergency service between February 15 and March 15, 2021 and had positive COVID-19 PCR test results. Though there was no statistically significant difference in symptoms between SARS-CoV-2 Alpha variant and classical variant (Wuhan type) groups; C-reactive protein (CRP), lymphocyte and leukocyte counts were statistically significantly higher in the Wuhan type group; prothrombin time (PT), International Normalized Ratio (INR) and serum creatinine values were statistically significantly higher in the Alpha group. Studies such as ours that investigate both the clinical features and laboratory data of SARS-CoV-2 variants will close the knowledge gaps, so better decisions may be made by health policy makers. Additional studies in this area will increase the understanding of the topic.

22 April 2025 in Microbiologia Medica
Verified
Journal Article
Open access
PDF file
DTDemet Timur
Demet Timur
ÖPÖmür Mustafa Parkan
Ömür Mustafa Parkan
EKEsma Gündüz Kaya
Esma Gündüz Kaya
Background: Pseudomonas aeruginosa is a major nosocomial pathogen that is hard to treat because of its multiple antibiotic resistance. In this study, we aimed to investigate the molecular epidemiology and antibiotic susceptibility of clinical P. aeruginosa isolates from Intensive Care Unit (ICU) patients in order to contribute to developing rational antibiotic usage policies and monitoring infection control precautions. Materials and Methods: seventy-five P. aeruginosa isolates from clinical specimens of patients in ICUs of Erciyes University Medical Faculty Hospital were studied. Bacterial identification was made using conventional methods and/or an automated Phoenix ID system (BD Diagnostics, Franklin Lakes, USA). The Minimal Inhibitory Concentration (MIC) for antibiotics was determined by broth microdilution. Repetitive sequence-based Polymerase Chain Reaction (rep-PCR) was used to assess the clonal relationship of the strains. Results: the resistance rates of the strains for amikacin, gentamicin, ciprofloxacin, levofloxacin, ceftazidime, cefepime, imipenem, meropenem, colistin were 2.7%,18.7%, 24%, 22.7%, 16%, 5.3%, 64%, 60%, and 1.3% respectively. According to rep-PCR results, 21 clones (A-U) were identified. It was found that 33.3% of the strains were in clone B, which was the dominant type. It was found that antibiotic susceptibility patterns of some clonally related isolates were similar. Conclusions: it is important to monitor resistance rates of infectious agents for guiding clinicians in empirical therapy and making rational antibiotic usage policies, it is also important to investigate clonal relationships for tracing the spread of infectious agents, especially multidrug-resistant pathogens and infection control precautions.